Epstein-Barr virus transcription in nasopharyngeal carcinoma

Sequences which encode Epstein-Barr virus (EBV) RNA in nasopharyngeal carcinoma (NPC) tissue have been identified. We utilized human biopsy material directly as well as NPC grown in nude mice. Total RNA was extracted from the tumor material and separated into polyadenylated and nonpolyadenylated fractions by oligodeoxythymidylate-cellulose chromatography. This material was used as template to construct 32P-labeled cDNA. The labeled cDNAs were hybridized to Southern blots of recombinant EBV DNA fragments. Three of the biopsies, F, 49, and 55, contained polyadenylated RNA homologous to the EBV BamHI fragments V and K, and EcoRI-DIJhet. These same fragments encode the most abundant polyribosomal RNAs in latently infected lymphoblastoid cell lines. The sequences which encoded nonpolyadenylated RNA in NPC tumor 49 were more extensive and included BamHI fragments C, V, B, E, and K, and EcoRI fragments DIJhet, E, F, and G1, a result that indicates selective polyadenylation in EBV RNA processing. A fourth biopsy, NPC tumor 18, contained polyadenylated RNA homologous to the BamHI fragments H, B, K, Y, B1, I1, and A and EcoRI fragments F and G2. A similar pattern of transcription was identified in three tumor specimens from nude mice, 4, 5, and 8. Transformation of lymphocytes did not occur after cocultivation in vitro with explants from these nude mice tumors. This transcriptional pattern may represent an activated state of the EBV genome, formerly not detected in tumor tissue, which is analogous to the state of abortive infection identified in induced in vitro cell systems.

[1]  E. Kieff,et al.  Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. , 1983, Science.

[2]  R. Weigel,et al.  Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters. , 1983, Virology.

[3]  E. Kieff,et al.  Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA , 1982, Journal of virology.

[4]  W. P. Summers,et al.  Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Kieff,et al.  Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Kieff,et al.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells , 1982, Journal of virology.

[7]  W. Henle,et al.  Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments , 1981, Journal of virology.

[8]  E. Kieff,et al.  Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells , 1981, Journal of virology.

[9]  E. Kieff,et al.  Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Pagano,et al.  Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis , 1981, Journal of virology.

[11]  E. Kieff,et al.  Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line , 1980, Journal of virology.

[12]  E. Kieff,et al.  DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative , 1980, Cell.

[13]  I. M. Shapiro,et al.  Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Kieff,et al.  Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Graessmann,et al.  Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[17]  W. Henle,et al.  Seroepidemiology of the Virus , 1979 .

[18]  E. Kieff,et al.  DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus , 1978, Journal of virology.

[19]  P. Seeburg,et al.  Nucleotide sequence of part of the gene for human chorionic somatomammotropin: Purification of DNA complementary to predominant mRNA species , 1977, Cell.

[20]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.

[21]  J. Taylor,et al.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase. , 1976, Biochimica et biophysica acta.

[22]  M. Epstein,et al.  Activation in vitro by BUdR of a productive eb virus infection in the epithelial cells of nasopharyngeal carcinoma , 1976, International journal of cancer.

[23]  W. Henle,et al.  Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma , 1976, International journal of cancer.

[24]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[25]  T. Lindahl,et al.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Hausen,et al.  EB viral genomes in epithelial nasopharyngeal carcinoma cells. , 1973, Nature: New biology.

[27]  W. Henle,et al.  Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. , 1973, Journal of the National Cancer Institute.

[28]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[29]  P. Leder,et al.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[31]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D T Denhardt,et al.  A membrane-filter technique for the detection of complementary DNA. , 1966, Biochemical and biophysical research communications.

[33]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.

[34]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.